Login
Home / LOVFF : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cannara Biotech Inc.

$1.41 +$0.11 (+8.23%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$1.43
Day Range
$1.41$1.43
Year Range
$1.11$1.47
Market Cap
138.99M
AVG Volume
13.7K
Trailing/Forward PE
17.52/6.67
PEG ratio
0.37
Dividend Yield
-
Next Earnings Date
2026-11-23
Primary Exchange
Other OTCUS
Revenue (CAD)
010M20M30M40M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Net Income (CAD)
-5M-2.5M02.5M5M7.5M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Operating Income (CAD)
-2.5M02.5M5M7.5M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EBITDA (CAD)
-2.5M02.5M5M7.5M10M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash Flows (CAD)
-5M05M10M15M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EPS (CAD)
-0.0500.050.124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Expenses (CAD)
05M10M15MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash & Debt (CAD)
020M40M60MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Debt ratios
012324 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Margins
0%20%40%60%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Return on Capital
-5%0%5%10%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Shares Outstanding
050M100M150M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Book Value Per Share (CAD)
00.511.524 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Total Assets (CAD)
050M100M150M200M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
PE Ratio
510152025med 13.18Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
0%2.5%5%7.5%10%12.5%med 7.95%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
0.511.52med 1.49Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
681012med 7.35Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
5101520med 7.69Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.511.522.5med 1.5Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Cannara Biotech Inc.
LOVFF
Stockpicker

Video analysis: LOVFF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LOVFF

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

globenewswire.com · 15 Jul 2026

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Cannara reports record Q3 2026 revenue, continued profitability, broader national distribution and accelerated capacity expansion to meet growing demand.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.